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Abstract  
Moyamoya disease associated with a germinoma has never yet been reported in the literature. 
This report describes a case of a cystic neurohypophysial germinoma associated with 
moyamoya disease. A fifteen-year-old girl with central diabetes insipidus was admitted to the 
hospital. A radiological examination revealed a suprasellar tumor and moyamoya disease.  
Surgery and a pathological study confirmed a pure germinoma. After the patient was treated 
with radiation and chemotherapy, the tumor was controlled without any effect on the 
moyamoya vessels. This report describes a rare incidental combination of moyamoya disease 
and a suprasellar germinoma. In the management of such cases, physicians should be aware of 
the symptoms, course, and natural history of both diseases and the effects and side effects of 
each type of therapy.  
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Introduction 
Moyamoya disease is an intracranial vascular disease characterized by stenosis of intracranial 
arteries and “moyamoya vessels”. There are some reports of moyamoya disease associated 
with brain tumors. However, no cases of moyamoya disease associated with a germinoma 
have ever been reported in the literature. This report describes a patient with a cystic 
neurohypophysial germinoma and moyamoya disease. The relationship between the two 
diseases and the management of the patient with these 2 different pathologies is discussed.  
Case report 
The patient was 15-year-old girl. She has experienced thirst and polyuria since November of 
2005. She had experienced amenorrhea since February 2006. Occasional headaches occurred, 
beginning in June 2006. She was referred to the hospital, because head computed tomography 
(CT) showed a suprasellar mass lesion. She had no remarkable medical or family history. She 
had no previous episodes of cerebral ischemia. Her right visual acuity was slightly decreased. 
No visual field defect was observed. There were no other neurological abnormalities. An 
endocrine examination revealed complete central diabetes insipidus and a low base line value 
of growth hormone and gonadotropin. Her menstrual cycle was irregular. The human 
chorionic gonadotropin (HCG)-β levels in her blood and cerebrospinal fluid were slightly 
elevated. Other tumor markers were normal. 
 Brain Magnetic resonance imaging (MRI) revealed a suprasellar cystic tumor of 
iso-intensity on T1 and T2 weighted images. The parenchymal part of tumor was 
homogeneously enhanced with gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA, 
Figure 1: coronal image). The tumor involved the optic nerve and pituitary grand. MRI and 
magnetic resonance angiography (MRA) showed a hypoplastic left internal carotid artery and 
left middle cerebral artery (MCA; not shown). Cerebral angiography confirmed the nearly 
complete occlusion of the internal carotid artery at the supraclinoid portion and left 
moyamoya vessels (Figure 2: A-P view). Neither tumor staining nor the compression of the 
cerebral vessels by the suprasellar tumor was observed. Technetium-99m ethyl cysteinate 
dimer single photon emission CT (ECD SPECT) at rest showed mild hypoperfusion in the left 
MCA area. After the intravenous injection of diamox, a sufficient increase of bilateral cerebral 
blood flow was recognized. 
  Tumor biopsy surgery was performed via a right pterional craniotomy to avoid potential 
damage to left moyamoya vessels. The right superficial temporal artery was preserved for 
future bypass surgery. During surgery, the PaCO2 was kept slightly high to maintain sufficient 
cerebral blood flow.  The tumor margin was not recognized under the surgical microscope. 
Swelling was recognized in the right optic nerve and chiasma. A cystic mass lesion was seen 
behind the chiasma and yellowish cyst fluid and tumor tissue in the cystic mass were removed 
for a pathological examination.  
 Pathologically, the tumor showed 2 cell patterns typical of a germinoma (Figure 3: 
Hematoxylin and Eosin staining, original magnification 400X). Immunostaining was positive 
staining for placental alkaline phosphatase (PLAP), and very low for HCG-β. There was no 
evidence of syncytiotrophblastic giant cells (STGC), so the pathological diagnosis was a pure 
germinoma. The Ki-67 labeling index was higher than 60%. 
 The patient received 2 cycles of chemotherapy consisting of carboplatin and etoposide. 
MRI after the 2 cycles of the chemotherapy showed a remarkable decrease of tumor. The 
patient received focal and whole ventricle fractionated conventional radiation therapy, with a 
total dose of 40 Gy. She underwent a third cycle of the same chemotherapy after the radiation. 
Then tumor disappeared on MRI. Tumor recurrence has not been seen at 2 years after the 
onset. The radiation and chemotherapy did not affect the cerebral blood flow. MRA and ECD 
SPECT showed same findings after the radiation and chemotherapy as in the initial studies. 
No symptoms associated with moyamoya disease have yet been observed.  
Discussion 
There are four possible mechanisms to explain a combination of a brain tumor and 
moyamoya disease (9). These are 1) Direct compression of arteries by the tumor, 2) secondary 
effects of radiation to the tumor, 3) combination with neurocutaneous syndrome, 4) incidental 
combination. In the present case, the moyamoya vessels were seen only in the left MCA area. 
There was no direct compression of the cerebral artery by tumor. Therefore, this case appears 
to represent an incidental combination.  
A literature search revealed 10 cases of incidental combination of a brain tumor and 
moyamoya disease (1-6,8,12,13) (Table 1). The ages of patients ranged from 3 to 66, the 
median age was 31.5 year-old. Most patient were children or young adults. There is no gender 
difference. There were 3 astrocytomas, 3 meningiomas, 3 pituitary adenomas and 1 
craniopharyngioma.  Moyamoya diseases were found during the investigation of the brain 
tumors in all of those patients. In some patients, the moyamoya disease became symptomatic 
after the therapy for the brain tumor. Some patients underwent revascularization surgery.  
The optimal treatment strategy for patients with a dual pathology remains to be elucidated. 
In the present case no symptoms associated with moyamoya disease have so far been 
observed. Radiation therapy might damage the intracranial artery and affect cerebral blood 
flow. We believe, however, the radiation therapy with an appropriate dose and field could not 
be avoided, because a germinoma is a lethal malignant tumor. Without appropriate radiation 
and chemotherapy tumor recurrence is inevitable and such tumor recurrence clearly threatens 
both the quality of life and survival itself (7,10). As a result, even though there is some risk of 
alterations in the cerebral blood flow due to a progression of the moyamoya disease in 
response to radiation therapy, since radiation should be administered to control the germinoma 
cells. Both the cerebral blood flow and possible tumor recurrence will be closely annually 
followed in this patient using ECD SPECT, Gd-DTPA enhanced MRI and MRA. 
Revascularization surgery would be considered if ischemic symptoms caused by moyamoya 
disease are later arise. 
Although cystic suprasellar (neurohypophysial) germinomas are very rare, one case has been 
previously reported (11). Cystic changes may cause rapid compression of the optic nerve or 
other parasellar structures. Complete surgical removal of the suprasellar tumor is not easy 
because there are many critical structures involved, such as the optic nerve, pituitary stalk and 
hypothalamus. The cyst itself was a well recognized good target of potential surgery. Surgical 
opening of the thin cyst wall is a less invasive procedure in comparison to the removal of a 
solid tumor. Cyst opening is also effective to decrease the tumor mass and limit the radiation 
field. Therefore, surgical cyst opening and tumor biopsy are a reasonable surgical strategy for 
treating a cystic suprasellar tumor. 
In conclusion this report described a rare incidental combination of moyamoya disease and a 
suprasellar germinoma. In the management of such cases, the physician should be aware of 
the symptoms, course and natural history of both diseases and the effects and side effects of 
each therapy.  
 
 Legend of figures 
Figure 1: Gd-DTPA enhanced coronal T1 weighted MRI shows an enhanced suprasellar cystic 
tumor. 
Figure 2: A-P view of the left internal carotid arteriogram shows stenosis of the carotid artery 
terminal and moyamoya vessels. 
Figure 3: Hematoxylin and eosin staining of the pathological specimen of the suprasellar 
tumor shows a mixture of large round tumor cells and small dense nuclear lymphocytes, the 
so-called two-cell pattern. (original magnification 400x) 
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 Table.1  
Reported cases of incidental combination of a brain tumor and moyamoya disease 
Case Age Sex pathology and location of brain tumor 
1 4 M Pilocytic astrocytoma at of cerebellar vermis 
2 40 F PRL-producing pituitary adenoma 
3 23 F PRL-producing pituitary adenoma 
4 3 M Craniopharyngioma 
5 40 F GH-producing adenoma 
6 44 F Malignant meningioma at temporo-occipital 
7 40 F Meningioma at sphenoid ridge 
8 66 M Secretory meningioma at left convexity 
9 8 M Pilocytic astrocytoma at brain stem 
10 11 M Astrocytoma at cerebellum 
11 15 F Germinoma at suprasellar (our case) 
 
 
